Gilead Sciences, Inc.
Executive Director, US Medical Affairs (USMA) Strategy – Liver and Covid
Gilead Sciences, Inc., California, Missouri, United States, 65018
Executive Director, US Medical Affairs (USMA) Strategy – Liver and Covid
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, primary biliary cholangitis and cancers. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Job Overview: The Executive Director (ED) USMA Strategy – Liver and Covid is a key member of the USMA leadership team, reporting to the VP of USMA, Virology, and office-based in Foster City, CA. This role is responsible for developing and driving the USMA strategies and respective medical annual plannings for Viral Hepatitis, Primary Biliary Cholangitis (PBC) and Covid-19 and provide representation in cross-functional HBV, HCV, HDV, PBC and COVID-19 working groups. The ED will oversee, develop, and maintain the tenor of Gilead's US scientific communications related to Viral Hepatitis, PBC and COVID-19 with the community of US health care professionals and advocates, ensuring high-quality deliverables such as medical affairs resources, medical presentations at conferences, advisory boards and medical engagements with US providers and advocates. Experience with launch planning and external collaborations will also be essential. Responsibilities: Develop, innovate, and execute USMA Viral Hepatitis, PBC and COVID-19 Plans of Action based on landscape assessment of unmet medical needs and anticipation of future industry trends and opportunities, collaborating with colleagues across the Development and US organization based in Foster City, CA. Serve as USMA Head of Liver and COVID-19 at cross-functional meetings, representing the US perspective and needs in working groups with respective Clinical Development, Global Medical Affairs, US Commercial, US Government Affairs and Policy, US Public Affairs, US Regulatory, and US legal and compliance. Represent US data gaps and research needs related to viral hepatitis, PBC and Covid-19. Assess medical education needs and generate insights related to liver and Covid-19 in the US healthcare. Provide scientific leadership at key US conferences. Provide inspirational leadership to the USMA Liver and COVID-19 Strategy teams by creating an environment of mutual respect, shared goals, clear responsibilities, and talent development. Essential Skills and Qualifications: M.D., D.O., PhD (in life sciences), PharmD, NP or PA with over 12 years of extensive experience in hepatology or infectious diseases; a minimum of 5 years of relevant Medical Affairs industry experience is required. Provide clear leadership and management in the development and delivery of a variety of highly complex projects with the ability to assess, understand and communicate the latest scientific information. Excellent strategic and organizational skills to manage direct reports and matrix teams with ability to anticipate, organize and prioritize workload on multiple ongoing projects and meet timelines in a fast-paced environment. Excellent analytical and critical thinking skills to assess the validity and relevance of study concepts, protocols, data results, and publications to lead prioritized US data generation and research needs. Must be fully cognizant and adhere to regulatory and legal (Business Conduct) requirements for US Medical Affairs activities. Able to work with a level of autonomy and independence and able to manage budgeting/oversight of operational expenses. Office-based position in Foster City, CA with the ability to travel up to 25 percent to attend cross-functional meetings and conferences. Gilead Core Values: Integrity (Doing What’s Right) Teamwork (Working Together) Excellence (Being Your Best) Accountability (Taking Personal Responsibility) Inclusion (Encouraging Diversity) The salary range for this position is: $341,190.00 - $441,540.00. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. For additional benefits information, visit:
Gilead Benefits As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws.
#J-18808-Ljbffr
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, primary biliary cholangitis and cancers. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Job Overview: The Executive Director (ED) USMA Strategy – Liver and Covid is a key member of the USMA leadership team, reporting to the VP of USMA, Virology, and office-based in Foster City, CA. This role is responsible for developing and driving the USMA strategies and respective medical annual plannings for Viral Hepatitis, Primary Biliary Cholangitis (PBC) and Covid-19 and provide representation in cross-functional HBV, HCV, HDV, PBC and COVID-19 working groups. The ED will oversee, develop, and maintain the tenor of Gilead's US scientific communications related to Viral Hepatitis, PBC and COVID-19 with the community of US health care professionals and advocates, ensuring high-quality deliverables such as medical affairs resources, medical presentations at conferences, advisory boards and medical engagements with US providers and advocates. Experience with launch planning and external collaborations will also be essential. Responsibilities: Develop, innovate, and execute USMA Viral Hepatitis, PBC and COVID-19 Plans of Action based on landscape assessment of unmet medical needs and anticipation of future industry trends and opportunities, collaborating with colleagues across the Development and US organization based in Foster City, CA. Serve as USMA Head of Liver and COVID-19 at cross-functional meetings, representing the US perspective and needs in working groups with respective Clinical Development, Global Medical Affairs, US Commercial, US Government Affairs and Policy, US Public Affairs, US Regulatory, and US legal and compliance. Represent US data gaps and research needs related to viral hepatitis, PBC and Covid-19. Assess medical education needs and generate insights related to liver and Covid-19 in the US healthcare. Provide scientific leadership at key US conferences. Provide inspirational leadership to the USMA Liver and COVID-19 Strategy teams by creating an environment of mutual respect, shared goals, clear responsibilities, and talent development. Essential Skills and Qualifications: M.D., D.O., PhD (in life sciences), PharmD, NP or PA with over 12 years of extensive experience in hepatology or infectious diseases; a minimum of 5 years of relevant Medical Affairs industry experience is required. Provide clear leadership and management in the development and delivery of a variety of highly complex projects with the ability to assess, understand and communicate the latest scientific information. Excellent strategic and organizational skills to manage direct reports and matrix teams with ability to anticipate, organize and prioritize workload on multiple ongoing projects and meet timelines in a fast-paced environment. Excellent analytical and critical thinking skills to assess the validity and relevance of study concepts, protocols, data results, and publications to lead prioritized US data generation and research needs. Must be fully cognizant and adhere to regulatory and legal (Business Conduct) requirements for US Medical Affairs activities. Able to work with a level of autonomy and independence and able to manage budgeting/oversight of operational expenses. Office-based position in Foster City, CA with the ability to travel up to 25 percent to attend cross-functional meetings and conferences. Gilead Core Values: Integrity (Doing What’s Right) Teamwork (Working Together) Excellence (Being Your Best) Accountability (Taking Personal Responsibility) Inclusion (Encouraging Diversity) The salary range for this position is: $341,190.00 - $441,540.00. Gilead considers a variety of factors when determining base compensation, including experience, qualifications, and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus, discretionary stock-based long-term incentives (eligibility may vary based on role), paid time off, and a benefits package. For additional benefits information, visit:
Gilead Benefits As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws.
#J-18808-Ljbffr